https://www.pharmaceutical-technology.com/data-insights/tivozanib-kyowa-kirin-diabetic-macular-edema-likelihood-of-approval/
Tivozanib is under clinical development by Kyowa Kirin and currently in Phase II for Diabetic Macular Edema.
diabetic macular edemakyowa kirintivozaniblikelihood
https://www.news-medical.net/news/20110328/AVEO-to-present-tivozanib-preclinical-data-monoclonal-antibody-pipeline-at-AACR-meeting.aspx
AVEO Pharmaceuticals, Inc. today announced that preclinical data on tivozanib, AVEO's lead product candidate designed to optimally block the VEGF pathway by...
monoclonal antibodyaveopresenttivozanibpreclinical